Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 200

2.

IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.

Zuo S, Liu C, Wang J, Wang F, Xu W, Cui S, Yuan L, Chen X, Fan W, Cui M, Song G.

J Cancer Res Clin Oncol. 2012 Jun;138(6):1045-55. doi: 10.1007/s00432-012-1153-y. Epub 2012 Mar 6.

PMID:
22392074
3.
4.

Role of p21 as a determinant of 1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl] diamantane response in human HCT-116 colon carcinoma cells.

Wang JJ, Hung HF, Huang ML, Lee HJ, Chern YT, Chang YF, Chi CW, Hsu YC.

Oncol Rep. 2012 Feb;27(2):529-34. doi: 10.3892/or.2011.1546. Epub 2011 Nov 10.

PMID:
22076474
5.

Cladosporol a stimulates G1-phase arrest of the cell cycle by up-regulation of p21(waf1/cip1) expression in human colon carcinoma HT-29 cells.

Zurlo D, Leone C, Assante G, Salzano S, Renzone G, Scaloni A, Foresta C, Colantuoni V, Lupo A.

Mol Carcinog. 2013 Jan;52(1):1-17. doi: 10.1002/mc.20872. Epub 2011 Oct 24.

PMID:
22025467
6.
7.

The p53-p21(Cip1/WAF1) pathway is necessary for cellular senescence induced by the inhibition of protein kinase CKII in human colon cancer cells.

Kang JY, Kim JJ, Jang SY, Bae YS.

Mol Cells. 2009 Nov 30;28(5):489-94. doi: 10.1007/s10059-009-0141-9. Epub 2009 Oct 21.

8.

Effect of Docosahexaenoic Acid on Cell Cycle Pathways in Breast Cell Lines With Different Transformation Degree.

Rescigno T, Capasso A, Tecce MF.

J Cell Physiol. 2016 Jun;231(6):1226-36. doi: 10.1002/jcp.25217. Epub 2015 Oct 26.

PMID:
26480024
9.
10.

Differential apoptosis by gallotannin in human colon cancer cells with distinct p53 status.

Al-Ayyoubi S, Gali-Muhtasib H.

Mol Carcinog. 2007 Mar;46(3):176-86.

PMID:
17192871
11.

Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin.

Shi Y, Felley-Bosco E, Marti TM, Orlowski K, Pruschy M, Stahel RA.

BMC Cancer. 2012 Dec 4;12:571. doi: 10.1186/1471-2407-12-571.

12.

Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells.

Watson JL, Hill R, Yaffe PB, Greenshields A, Walsh M, Lee PW, Giacomantonio CA, Hoskin DW.

Cancer Lett. 2010 Nov 1;297(1):1-8. doi: 10.1016/j.canlet.2010.04.018. Epub 2010 May 15.

PMID:
20472336
13.

LYG-202 inhibits the proliferation of human colorectal carcinoma HCT-116 cells through induction of G1/S cell cycle arrest and apoptosis via p53 and p21(WAF1/Cip1) expression.

Liu W, Dai Q, Lu N, Wei L, Ha J, Rong J, Mu R, You Q, Li Z, Guo Q.

Biochem Cell Biol. 2011 Jun;89(3):287-98. doi: 10.1139/O10-162. Epub 2011 Apr 14.

PMID:
21491996
14.

p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine.

Zheng F, Tang Q, Wu J, Zhao S, Liang Z, Li L, Wu W, Hann S.

J Exp Clin Cancer Res. 2014 Apr 26;33:36. doi: 10.1186/1756-9966-33-36.

17.

The indole-3-carbinol cyclic tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines.

De Santi M, Galluzzi L, Lucarini S, Paoletti MF, Fraternale A, Duranti A, De Marco C, Fanelli M, Zaffaroni N, Brandi G, Magnani M.

Breast Cancer Res. 2011 Mar 24;13(2):R33. doi: 10.1186/bcr2855.

18.

The p53-p21WAF1 checkpoint pathway plays a protective role in preventing DNA rereplication induced by abrogation of FOXF1 function.

Lo PK, Lee JS, Sukumar S.

Cell Signal. 2012 Jan;24(1):316-24. doi: 10.1016/j.cellsig.2011.09.017. Epub 2011 Sep 22.

19.

Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cells.

Ramana KV, Tammali R, Srivastava SK.

Mol Cancer Ther. 2010 Apr;9(4):813-24. doi: 10.1158/1535-7163.MCT-09-0795. Epub 2010 Mar 30.

20.

Difference of cell cycle arrests induced by lidamycin in human breast cancer cells.

Liu X, He H, Feng Y, Zhang M, Ren K, Shao R.

Anticancer Drugs. 2006 Feb;17(2):173-9.

PMID:
16428935

Supplemental Content

Support Center